Annual SG&A
$41.74 M
-$1.66 M-3.83%
31 December 2023
Summary:
Kronos Bio annual selling, general & administrative expenses is currently $41.74 million, with the most recent change of -$1.66 million (-3.83%) on 31 December 2023. During the last 3 years, it has risen by +$26.95 million (+182.13%). KRON annual SG&A is now -3.83% below its all-time high of $43.40 million, reached on 31 December 2022.KRON Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.82 M
-$550.00 K-8.64%
30 September 2024
Summary:
Kronos Bio quarterly selling, general & administrative expenses is currently $5.82 million, with the most recent change of -$550.00 thousand (-8.64%) on 30 September 2024. Over the past year, it has dropped by -$3.58 million (-38.09%). KRON quarterly SG&A is now -51.43% below its all-time high of $11.98 million, reached on 31 December 2023.KRON Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.17 B
-$85.59 M-4.10%
30 September 2024
Summary:
Kronos Bio TTM selling, general & administrative expenses is currently -$2.17 billion, with the most recent change of -$85.59 million (-4.10%) on 30 September 2024. Over the past year, it has dropped by -$2.21 billion (-5492.49%). KRON TTM SG&A is now -9156.78% below its all-time high of $44.47 million, reached on 30 September 2022.KRON TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRON Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.8% | -38.1% | -5492.5% |
| 3 y3 years | +182.1% | -35.3% | -6328.2% |
| 5 y5 years | +2489.3% | +630.0% | -10000.0% |
KRON Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.8% | +182.1% | -51.4% | at low | -251.7% | at low |
| 5 y | 5 years | -3.8% | +2489.3% | -51.4% | +630.0% | -9156.8% | at low |
| alltime | all time | -3.8% | +2489.3% | -51.4% | +630.0% | -9156.8% | at low |
Kronos Bio Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.82 M(-8.6%) | $31.67 M(-10.2%) |
| June 2024 | - | $6.37 M(-15.2%) | $35.25 M(-10.1%) |
| Mar 2024 | - | $7.51 M(-37.3%) | $39.19 M(-6.1%) |
| Dec 2023 | $41.74 M(-3.8%) | $11.98 M(+27.5%) | $41.74 M(+3.6%) |
| Sept 2023 | - | $9.40 M(-8.8%) | $40.27 M(-1.8%) |
| June 2023 | - | $10.31 M(+2.5%) | $41.01 M(-1.2%) |
| Mar 2023 | - | $10.06 M(-4.4%) | $41.53 M(-4.3%) |
| Dec 2022 | $43.40 M(+12.7%) | $10.51 M(+3.7%) | $43.40 M(-2.4%) |
| Sept 2022 | - | $10.13 M(-6.4%) | $44.47 M(+2.7%) |
| June 2022 | - | $10.82 M(-9.2%) | $43.32 M(+3.5%) |
| Mar 2022 | - | $11.93 M(+2.9%) | $41.84 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $38.49 M(+160.2%) | $11.59 M(+29.0%) | $38.49 M(+10.4%) |
| Sept 2021 | - | $8.98 M(-3.8%) | $34.87 M(+16.5%) |
| June 2021 | - | $9.34 M(+8.8%) | $29.94 M(+34.7%) |
| Mar 2021 | - | $8.58 M(+7.8%) | $22.22 M(+50.2%) |
| Dec 2020 | $14.79 M(+339.0%) | $7.96 M(+96.4%) | $14.79 M(+86.3%) |
| Sept 2020 | - | $4.05 M(+149.8%) | $7.94 M(+69.6%) |
| June 2020 | - | $1.62 M(+40.6%) | $4.68 M(+53.1%) |
| Mar 2020 | - | $1.15 M(+4.2%) | $3.06 M(+60.6%) |
| Dec 2019 | $3.37 M(+109.1%) | $1.11 M(+39.0%) | $1.91 M(+139.0%) |
| Sept 2019 | - | $797.00 K | $797.00 K |
| Dec 2018 | $1.61 M | - | - |
FAQ
- What is Kronos Bio annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Kronos Bio?
- What is Kronos Bio annual SG&A year-on-year change?
- What is Kronos Bio quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Kronos Bio?
- What is Kronos Bio quarterly SG&A year-on-year change?
- What is Kronos Bio TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Kronos Bio?
- What is Kronos Bio TTM SG&A year-on-year change?
What is Kronos Bio annual selling, general & administrative expenses?
The current annual SG&A of KRON is $41.74 M
What is the all time high annual SG&A for Kronos Bio?
Kronos Bio all-time high annual selling, general & administrative expenses is $43.40 M
What is Kronos Bio annual SG&A year-on-year change?
Over the past year, KRON annual selling, general & administrative expenses has changed by -$1.66 M (-3.83%)
What is Kronos Bio quarterly selling, general & administrative expenses?
The current quarterly SG&A of KRON is $5.82 M
What is the all time high quarterly SG&A for Kronos Bio?
Kronos Bio all-time high quarterly selling, general & administrative expenses is $11.98 M
What is Kronos Bio quarterly SG&A year-on-year change?
Over the past year, KRON quarterly selling, general & administrative expenses has changed by -$3.58 M (-38.09%)
What is Kronos Bio TTM selling, general & administrative expenses?
The current TTM SG&A of KRON is -$2.17 B
What is the all time high TTM SG&A for Kronos Bio?
Kronos Bio all-time high TTM selling, general & administrative expenses is $44.47 M
What is Kronos Bio TTM SG&A year-on-year change?
Over the past year, KRON TTM selling, general & administrative expenses has changed by -$2.21 B (-5492.49%)